"/> Novus Biologicals™ Peptide bloquant d’anticorps KA… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps KA1/GRIK4/Glutamate Receptor KA1

Réf. : BL-RE-085074Réf. fabricant : 18278195 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
2900
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76852. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 14 amino acids near the amino terminus of human Grik4.

Points forts

Source

Synthetic

(Accession #: Q16099) The KA1/GRIK4/Glutamate Receptor KA1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085074
Réf. fabricant18278195
Gene ID (Entrez)2900
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76852. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEAA1, Excitatory amino acid receptor 1, glutamate receptor KA1, Glutamate receptor KA-1, glutamate receptor, ionotropic kainate 4, glutamate receptor, ionotropic, kainate 4, KA1GRIK
Symbole de gène(s)GRIK4
Type de produitKA1/GRIK4/Glutamate Receptor KA1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne14 amino acids near the amino terminus of human Grik4
Une question, une configuration particulière ?
Contactez-nous pour un devis.